Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond

Purpose: Radiotherapy is integral in the management of hematological malignancies (HM). Standard radiotherapy dose fractionation regimens range between 20 and 50 Gy in 10–25 fractions over 2–5 weeks. This study presents the outcomes of patients with HM treated with hypofractionation radiotherapy (HF...

Cijeli opis

Bibliografski detalji

Glavni autori:	Febin Antony, Arbind Dubey, Pamela Skrabek, Lung Fung Tsang, Pascal Lambert, Bohdan Bybel, Naseer Ahmed
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-01-01
Serija:	Current Oncology
Teme:	lymphomas hypofractionation radiotherapy
Online pristup:	https://www.mdpi.com/1718-7729/31/1/25
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!